|
|
Thomson Financial Business Description:
| The Group's principal activity is that of therapeutic research and development. The Group has undertaken to develop therapeutics based on the unique and proprietory Gene ICE platform and Hypergenomics technology. The Group intends to exploit opportunities in the future healthcare, life sciences and biopharmaceutical industries. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on ValiRx plc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
